3D Bioprinting Market 2022-2027: Industry Report, Growth, Analysis and Forecast

3D Bioprinting Market

According to IMARC Group latest report titled “3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on 3D bioprinting market report 2022. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global 3D bioprinting market reached a value of US$ 721.9 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,260.1 Million by 2027, exhibiting at a CAGR of 16.85% during 2022-2027.

3D bioprinting refers to the medical application of 3D printers for fabricating biological tissues and organs through the layering of living cells. It creates spatially-controlled patterns in 3D where viability and cell function are conserved within the printed construct. 3D bioprinting utilizes a layer-by-layer method to deposit materials like bio-inks. Bio-inks are obtained from living cells, biomaterials, and active biomolecules to create the 3D structure of tissues and organs. The technology offers speedy and accurate drug testing as potential drug compounds can be tested on bio-printed tissue before being used in human trials. It is also used to build complex bodily structures, including bones, skin, vascular grafts, tracheal splints, heart tissues, and cartilages. As a result, 3D bioprinting finds applications in the research and development of drugs, scaffolds, and medical implants.

Request to Get the Free Sample Report: https://www.imarcgroup.com/3d-bioprinting-market/requestsample 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Market Trends:

The market is primarily driven by the increasing geriatric population and rising instances of respiratory and cardiovascular diseases that require organ transplants. The limited number of organ donors is propelling the demand for 3D bioprinting across healthcare organizations. In addition to this, the technology is used in cosmetic surgeries and the pharmaceutical industry, further supplementing the market growth. This has also resulted in growing public and private fundings, which have prompted market players to improve and strengthen their manufacturing and distribution capabilities. As a result, 3D bioprinting is used to create simple tissue structures in a lab setting; however, it can also build complete organs for transplants in the future, owing to technological advancements and the manufacturing of customized products. Moreover, manufacturers have introduced organ-on-a-chip and bio-printed structures that enable a 3D in-vitro analysis of bodily functions and aids in developing artificial organs and tissues. Furthermore, extensive R&D investments and increasing stem cell research have increased awareness regarding 3D bioprinting, which is positively influencing the market growth.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/3d-bioprinting-market

Competitive Landscape with Key players:

The report has also analysed the competitive landscape of the market with some of the key players being.

  • 3D Systems Inc.
  • Aspect Biosystems Ltd.
  • Cellink, Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH
  • Materialise
  • Organovo Holdings Inc.
  • Poietis, RegenHU
  • Stratasys Ltd

3D Bioprinting Market Segmentation:

Our report has categorized the market based on region, component, application and end use industry.

Breakup by Component:

  • 3D Bioprinters
  • Syringe/Extrusion Bioprinting
  • Inkjet Bioprinting
  • Magnetic Levitation Bioprinting
  • Laser-assisted Bioprinting
  • Others
  • Scaffolds
  • Biomaterials
  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Others

Breakup by Application:

  • Research
  • Drug Research
  • Regenerative Medicine
  • 3D Cell Culture
  • Clinical
  • Skin
  • Bone and Cartilage
  • Blood Vessels
  • Others

 Breakup by End User:

  • Hospitals
  • Research Organization and Academic Institutes
  • Biopharmaceuticals Companies

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *